Willis Towers Watson's SWOT analysis: stock outlook amid strategic shifts

Willis Towers Watson (WTW) recently reported adjusted EPS of $8.13, exceeding estimates, driven by strong margins in Risk & Broking and Human Capital & Benefits segments, with organic growth at 5%. The company is strategically shifting towards higher-margin Retirement & Benefits services, aiming for 45% of the business by 2025, and plans to deploy over $1.5 billion annually for buybacks and M&A. While analysts project EPS growth and improved free cash flow, concerns remain about historical FCF conversion issues and underperformance in the Health, Wealth & Career segment, leading to mixed outlooks with price targets ranging from $315 to $408.

Analysis

Willis Towers Watson (WTW) is demonstrating progress in its "Grow, Simplify, and Transform" strategy, evidenced by recent financial outperformance and strategic shifts. The company reported adjusted EPS of $8.13, surpassing the $8.03 consensus, largely due to improved margins in its Risk & Broking (R&B) and Human Capital & Benefits (HWC) segments. Organic growth met expectations at 5%, despite the intentional slowing of Tranzact prior to its year-end sale. A notable highlight is the significant improvement in free cash flow (FCF), which increased approximately 17% year-over-year to $569 million, resulting in an FCF margin of roughly 19%, comfortably exceeding consensus. WTW's strategic pivot towards higher-margin Retirement & Benefits services, targeted to comprise 45% of the business by 2025 from 40% in 2021-22, along with plans to deploy over $1.5 billion annually for share buybacks and M&A, signals a clear focus on enhancing shareholder value and earnings growth. While analysts project EPS expansion to $18.10 in 2025 and $20.73 in 2026, and FCF yield improvement from 14.0% in 2024 to 18.0% in 2026, some concerns persist. These include the sustainability of FCF conversion improvements given historical challenges and specific drags like capitalized software costs and tax payments, and the persistent underperformance of the Health, Wealth & Career (HWC) segment, despite an expected boost to the Health sub-segment from regulatory changes. The mixed analyst outlook, with price targets ranging from $315 to $408 and 11 recent downward earnings revisions, reflects this balance of positive strategic execution against ongoing operational challenges and a competitive landscape.

Key Decisions for Investors

• Investors should monitor WTW's upcoming quarterly reports closely, focusing on sustained free cash flow conversion rates and signs of a turnaround in the Health, Wealth & Career segment's performance to validate the efficacy of its transformation strategy.
• Consider the company's aggressive capital deployment plan, including over $1.5 billion annually for buybacks and M&A, as a potential catalyst for EPS accretion and value creation, but weigh this against the mixed analyst sentiment and historical FCF concerns.
• Evaluate WTW's progress in shifting its business mix towards the targeted 45% in higher-margin Retirement & Benefits services by 2025, as success in this area is crucial for achieving projected margin expansion and narrowing the valuation gap with peers.